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Synergistic Antibacterial Effects of 
Metallic Nanoparticle Combinations
c. Bankier1, R. K. Matharu1,2, Y. K. Cheong  3, G. G. Ren  3, e. cloutman-Green1,4 & L. ciric1*
Metallic nanoparticles have unique antimicrobial properties that make them suitable for use within 
medical and pharmaceutical devices to prevent the spread of infection in healthcare. The use of 
nanoparticles in healthcare is on the increase with silver being used in many devices. However, not all 
metallic nanoparticles can target and kill all disease-causing bacteria. To overcome this, a combination 
of several different metallic nanoparticles were used in this study to compare effects of multiple 
metallic nanoparticles when in combination than when used singly, as single elemental nanoparticles 
(SENPs), against two common hospital acquired pathogens (Staphylococcus aureus and Pseudomonas. 
aeruginosa). Flow cytometry LIVE/DEAD assay was used to determine rates of cell death within a 
bacterial population when exposed to the nanoparticles. Results were analysed using linear models 
to compare effectiveness of three different metallic nanoparticles, tungsten carbide (WC), silver (Ag) 
and copper (Cu), in combination and separately. Results show that when the nanoparticles are placed 
in combination (NPCs), antimicrobial effects significantly increase than when compared with SENPs 
(p < 0.01). This study demonstrates that certain metallic nanoparticles can be used in combination 
to improve the antimicrobial efficiency in destroying morphologically distinct pathogens within the 
healthcare and pharmaceutical industry.
Nanotechnology has played a crucial role in the advancement of a variety of fields. In particular, nanoparticles 
(NPs) have been widely utilised in several industries, ranging from biomedicine to engineering, due to their 
unique size-dependent physical and chemical properties (e.g. high surface to volume ratio)1. One example is 
the use of biodegradable NPs for drug delivery whereby the active ingredient can adsorb or absorb to the NP 
which can then deliver it to targeted areas2. Furthermore, several metallic NPs are widely accepted as having 
antimicrobial properties with many, in particular silver, now being used in medical devices to help decontaminate 
equipment and prevent the spread of infectious disease3. More recently, metallic NPs have been used in combina-
tion with certain antibiotics to help overcome resistant bacteria and enhance antibiotic effects4,5. However, these 
therapies are designed to be used once symptoms of infection manifest and certain metallic NPs can be toxic to 
mammalian cells when used internally as therapeutics6.
Industry and healthcare are keen to develop new ways to prevent and control infection by using materials that 
target a broad-spectrum of microbes whilst remaining non-toxic to human cells when used indirectly in patient 
care (i.e. medical devices, surfaces and manufacturing of drugs). NPs could offer a novel way to reduce the cost 
and use of multiple disinfectants and procedures by integrating these antimicrobial particles into clinical and 
industrial devices. Multiple studies have shown strong antimicrobial effects of metallic NPs to multiple species of 
bacteria7–11. However, it has also been shown that although certain NPs might be effective antimicrobials against 
certain bacteria, they may have little or no effect on others. Ideally, when using NPs integrated into devices to 
prevent contamination, a broad spectrum NP would be used to target multiple species of bacteria. Using a com-
bination of metallic NPs that can target a broad-spectrum of pathogens could be an effective solution for devices 
used in healthcare.
Different NPs employ different mechanisms to destroy bacteria and in particular metallic NPs are known to 
use several modes of action to do this. NPs have been shown to penetrate the bacterial cell wall and form pores on 
the surface of the membrane which, in turn, causes free radical formation which can also destroy the cell mem-
brane12. Ions from the NPs can interfere with enzyme production and generate reactive oxygen species (ROS). 
DNA transcription has also been shown to be affected13.
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Staphylococcus aureus and Pseudomonas aeruginosa are two pathogens of concern to the healthcare and phar-
maceutical industry as they are highly resistant to antibiotics14,15. In healthcare, it is common for P. aeruginosa 
to form biofilms in equipment which can lead to respiratory infections like ventilator associated pneumonia in 
immunocompromised patients16. S. aureus and P. aeruginosa are known to cause critical illness through skin, 
ear and eye infections and are notoriously difficult to treat due to resistance to numerous therapies14. Many 
studies have shown antimicrobial effects of single metallic NPs on these pathogens and therefore, by integrating 
different combinations of known antimicrobial metallic NPs (such as aluminimum oxide, zinc oxide, titanium 
dioxide, nickel oxide and silver) within devices at specific concentrations could prevent contamination by these 
pathogens8,17–19.
In this study, the effects of single elemental nanoparticles (SENPs) - silver, copper and tungsten carbide - on 
Gram-positive (S. aureus) and Gram-negative (P. aeruginosa) bacteria were analysed. Silver and copper NPs were 
chosen for this study as they are common antibacterial agents, tungsten carbide was also chosen as though the 
antiviral properties of this material have been previously reported, the antibacterial properties are unknown20,21. 
Further to this, the effects of a combinations of nanoparticles (NPCs) of the same elements together in differ-
ent ratios were investigated on the same bacterial species at various concentrations (0.05, 0.10 and 0.25 w/v %) 
to determine the strongest antibacterial effect. The effects of the SENPs and NPCs on both species have been 
assessed by quantifying the proportions of live and dead cells after exposure to these NP treatments after 24 hours. 
Quantification of bacterial cells was performed using flow cytometry and the synergistic effects of NPCs were 
compared to SENPs.
Results
To determine the antibacterial effect of SENPs and NPCs on P. aeruginosa and S. aureus, populations of live and 
dead bacteria were quantified using flow cytometry after treatment.
Single elemental nanoparticles (SENP). Figure 1 shows the results obtained when S. aureus and P. 
aeruginosa were exposed to SENPs for 24 hours. In this figure the control samples represent the bacterial popula-
tion prior to SENP exposure. The green bars show the proportion of ‘live’ cells whilst the red bars symbolise the 
proportion of ‘dead’ cells in suspension after incubation. From these results it can be concluded that WC did not 
exhibit any antibacterial activity against P. aeruginosa as a large proportion of the cells were still alive (∼98% ± 
0.38). However, a strong antimicrobial effect was observed for all concentrations of Ag (>99% dead) and Cu with 
most cells showing damaged membranes (>98%). Furthermore, it was also noted that the antibacterial activity of 
Ag and Cu NPs against P. aeruginosa was not dose dependent.
Similarly, WC NPs did not show any antimicrobial effect on S. aureus (>99% ± 0.14 live), whereas Ag NPs dis-
played some mild cytotoxic activity at higher concentrations (9% ± 0.9 dead at 0.25 w/v %) but this was still not 
as effective as it was on P. aeruginosa. Cu NPs showed antimicrobial properties towards S. aureus cells at higher 
concentrations (at 0.10 w/v%, 55%, ±3.4 of the cells were dead, whilst at 0.25 w/v %, ~99% ± 0.08 of the tested 
population was dead), therefore indicating antimicrobial activity was dose dependent.
Figure 1. Exposure of (a) P. aeruginosa and (b) S. aureus to single elemental nanoparticles (SENPs). Green 
shows live cells and red shows proportion of dead cells (n = 3).
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A one-way ANOVA showed a significant difference between proportions of live and dead cells for P. aerugi-
nosa (F3,26 = 17025, P = 0.0001) with post hoc TukeyHSD showing significant differences between all nanoparti-
cles (P = 0.0001) with the exception of Ag compared with Cu (P = 0.155).
Similarly, for S. aureus, there was also an overall significant difference between live and dead cells (F3,26 = 9.012, 
P = 0.0002). TukeysHSD shows a significant difference between Cu with the control, WC and Ag (P < 0.001) with 
no significant difference shown between WC, control or Ag (P = 0.9).
Nanoparticle combinations (NPC). To determine the antimicrobial effect of the SENPs when in combi-
nation (NPCs), populations of live and dead bacterial cells were analysed after exposure (Fig. 2). The NPCs were 
named as shown in Table 1.
Antimicrobial effects of NPCs were most pronounced against P. aeruginosa with all NPCs showing cell death 
at >90% for all concentrations. All NPCs, other than Ag20Cu70WC10, were most effective on S. aureus with 
>80% killing rate after exposure. However, Ag20Cu70WC10 did not show as potent an effect with only 40% 
±0.55 cell death at the lowest concentration (0.05 w/v %) and increasing to ∼50% ± 0.71 at the highest concen-
tration (0.25 w/v %).
A one-way ANOVA revealed a significant difference overall for P. aeruginosa and S. aureus for all treatments 
(F5,10 = 1141, P = 0.0001. F5,10 = 44.2, P = 0.0001, respectively). The post hoc TukeyHSD for P. aeruginosa data, 
significant differences were shown for Ag40Cu10WC50 and all other combinations of particles and the con-
trol (P < 0.001). There was no significance between Ag10Cu40WC50, Ag20Cu30WC50, Ag20Cu50WC30 and 
Ag20Cu70WC10 (P > 0.92).
Figure 2. Exposure of (a) P. aeruginosa and (b) S. aureus to nanoparticle combinations (NPCs). Green shows 
live cells and red shows proportion of dead cells (n = 3).
Nanocomposite 
Formulation
Weight Ratio of Each Nanoparticle 
Component (w/w%)
Silver Copper
Tungsten 
Carbide
Ag 100 — —
Cu — 100 —
WC — — 100
Ag40Cu10WC50 40 10 50
Ag10Cu40WC50 10 40 50
Ag20Cu30WC50 20 30 50
Ag20Cu50WC30 20 50 30
Ag20Cu70WC10 20 70 10
Table 1. Composition of Antimicrobial Nanoparticle Formulations.
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Similar results are shown for S. aureus, however, the antimicrobial effect is less evident with some cells sur-
viving after exposure to treatment (green bars), in particular, Ag20Cu70WC10. Post hoc TukeyHSD shows a 
significant difference between the controls and NPCs (P < 0.0001). However, no significant difference was shown 
between Ag40Cu10WC50, Ag10Cu40WC50, Ag20Cu30WC50 and Ag20Cu50WC30 (P > 0.80). Ag20Cu70WC10 
treatment was significantly less effective when compared with all other treatments (P < 0.0001).
For S. aureus, there is a trend of increasing cell death as concentrations of NPCs increase (from 0.05 to 0.25 w/v 
%) but antimicrobial effects are not as strong when compared to P. aeruginosa. It was also noted that, at higher 
concentrations, the NPCs were more toxic towards P. aeruginosa, as a stronger kill was observed.
Single elemental nanoparticles vs nanoparticle combinations. To help visualise the potential syn-
ergistic antimicrobial effects of each SENP (WC, Ag and Cu) and NPCs, the mean of each SENP and NPC tested 
was calculated for all concentrations (Fig. 3). Results show that, for P. aeruginosa, there is a significant variation 
in the proportion of dead cells between SENP and NPC, but this remained relatively consistent across all NPCs 
tested (one-way ANOVA: F1,40 = 6.6, P = 0.01). Similarly, for S. aureus, there was a significant difference in cell 
death rates between SENP and NPC (one-way ANOVA: F1,40 = 41, P = 0.0001). SENP treatment showed low 
percentages of dead cells (0–10%) whilst NPC showed a significantly higher rate of cell death of between ∼77 
and 88%.
Discussion
Various metallic NPs are widely known to have antimicrobial effects, however, not all metallic NPs can destroy all 
types of bacteria. Therefore, when integrating NPs into healthcare or pharmaceutical devices, it is desirable to use 
a combination of NPs to target a broad-spectrum of pathogens. Silver and copper NPs have been used for decades 
as antimicrobials in multiple devices, however, implementation of these NPs into modern devices has been slow, 
possibly due to the specificity of the NPs to certain bacteria22.
Herein, the antimicrobial effect of SENPs at three different concentrations (0.05, 0.10 and 0.25 w/v %) were 
compared in two known distinctively different pathogens (Gram-positive S. aureus and Gram-negative P. aerugi-
nosa). The SENPs were then combined together in different ratios and their antimicrobial effect tested on the two 
pathogens.
Results showed Ag SENPs had strong antibacterial effects on P. aeruginosa and no antibacterial effects on S. 
aureus, Cu SENPs had antimicrobial effects on P. aeruginosa and moderate cytotoxicity against S. aureus whereas 
WC NPs did not show any effect on the bacterial cells (Fig. 1). It was also noted that the antimicrobial effects of Ag 
(at all concentrations) and Cu (at 0.05 and 0.10 w/v%) SENPs were less pronounced against S. aureus.
The Ag SENPs used in this study exhibited strong antibacterial activity. In this research, when minimum 
dose of 0.05 w/v% (which equates to 0.5 mg/mL) was used against P. aeruginosa, 99% of the bacterial population 
was killed. This concentration is significnaly lower, when compared to the minimum inhibitory concentration 
Figure 3. Boxplot showing mean % cell death for all SENP and NPCs for (a) P. aeruginosa and (b) S. aureus. 
The top and bottom boundaries of each box indicate upper and lower quartile values, and black horizontal lines 
inside each box represent the median. Ends of the whiskers mark the lowest and highest % cell death observed 
from each treatment. Asterisk represent the mean and dots show outliers.
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reported by Punjabi et al. for the same bacteria strain (2.5 mg/mL)23. However, similarly, Punjabi et al. also noted 
that a higher nanoparticle concentration (5 mg/mL) is required in order to be effective against S. aureus23. This 
was also observed in the presented study, as a Ag SENP concentration of 0.25 w/v% only resulted in moderate 
cytotoxicity. The antibacterial activity of Ag SENPs has been attributed to three distinct mechanisms: firstly, it is 
thought that the Ag NPs bind to the surface of the cell membrane thus altering basic cellular functions including 
permeability and respiration (production of reactive oxygen species); secondly, it has also been reported that Ag 
NPs penetrate inside the bacterial cell and cause damage by interacting with sulfur- and phosphorus- containing 
compounds such as DNA; thirdly, studies have shown the Ag NPs to release Ag ions which then deposit in the cell 
and along the cell wall as granules, consequently inhibiting cell division, damaging the integtrity of the cell mem-
brane and wall and interefering with the cellular content24–31. It is plausible that all three destructive mechanisms 
work simulutanously to cause microbial death.
In the case of Cu NPs, the antibacterial mode of action is thought to be multifaceted, whereby the release of Cu 
ions is the primary cytotoxic mechanism27,32,33. The Cu ions interact either directly with the cellular membrane 
or intracellulary to produce free-radicals. Alternative hypothetical mechanisms include the accumulation and 
dissolution of NPs in the bacterial membrane changing its permeability, with subsequent release of intracellular 
biomolecules and dissipation of the proton motive force across the plasma membrane27,34–36.
When using the NPs in combination (NPCs composition displayed in Table 1), a more pronounced antimi-
crobial effect was observed for both bacterial species with a high cell death rate for P. aeruginosa and S. aureus 
(Ag40Cu10WC50, Ag10Cu40WC50, Ag20Cu30WC50 and Ag20Cu50WC30) (Fig. 2). This was then corrobo-
rated further by showing that on average, NPCs can significantly improve the antimicrobial performance when 
compared to SENPs (Fig. 3).
This more pronounced antimicrobial effect is thought to be due to the ratios of NPs within each combination 
(Table 1). As a high cell death rate was observed for P. aeruginosa for all NPCs, it can be assumed that this is 
attributed to the Ag NP (Ag, Fig. 1) which were effective at killing P. aeruginosa cells in the SENP form. However, 
for S. aureus, the reason for the higher rate of cell death when NPs are in combination than when single elements 
is less clear. Ag20Cu70WC10, which did not have a strong antimicrobial effect, showed to have the highest quan-
tity of copper with a small amount of silver. It is thought that copper nanoparticles might cause pores to form in 
Gram-positive S. aureus cell membrane which could allow silver particles to penetrate and destroy the cell. It has 
been shown previously that this type of mechanism can cause damage to cell membranes whilst being unrelated to 
oxidative stress37. As cell membranes act as important defence barriers for bacteria, the mechanism in which NPs 
are absorbed differs between Gram-positive and Gram-negative organisms which could explain the differences 
shown here. Gram-positive bacteria have a thicker (multi-layered) peptidoglycan exterior wall, functionalised 
with teichoic acid and tend to be more porous38. Whereas, Gram-negative bacteria have a single peptidoglycan 
layer followed by an outer membrane that is densely populated with lipopolysaccharides. However, although 
these physiological factors might contribute to susceptibility to antimicrobials, here, a reduced antimicrobial 
effect for Gram-positive than Gram-negative bacteria was observed. Similar results were shown in a study by Kim 
et al., (2007), which demonstrated Ag NPs to be effective against Gram-negative E. coli but not Gram-positive S. 
aureus26. They concluded this was due to a difference in cell wall structure between the two pathogens and type 
of NP used26. However, cell wall structure alone does not fully explain the potential for a NP to be antimicrobial. 
Several physico-chemical factors can contribute to the antimicrobial potential of a nanoparticle, such as size, 
shape and charge. Gram-positive organisms tend to attract positively charged ionic NPs due to their negatively 
charged cell wall, however, not all NPs are positively charged19. The size and shape of NPs can significantly affect 
their bactericidal properties. A smooth surface area can increase the potential for contact with a bacterial cell. The 
NPs tested here were tested in solution (LB broth), which could cause the particles to coagulate or reduce their 
stability which might reduce potency towards S. aureus, as suggested by Pal et al., (2007) when testing silver NPs 
in broth against E. coli39. A recent study by Garza-Cervantes et al. (2017) has shown that Cu, Zn and Ni may all 
increase prokaryotic cell memberane permeability when combined with Ag NPs11. The mode of action of metallic 
antimicrobial NPs on microbial cells is still very much under debate and rests on little data and many hypotheses 
as outlined by Shaikh et al. (2019) in a recent review of the litarature40.
Tungsten carbide (WC) was not shown to have any antimicrobial effect on either S. aureus or P. aeruginosa. 
For SENP, no antimicrobial effect was shown and therefore it is not thought that tungsten contributed to any anti-
microbial impact on the bacterial cells when placed in combination (NPCs). It has previously been shown that 
tungsten does have antimicrobial effects against S. aureus caused by reactive oxygen species (ROS) when the NPs 
were shown to be <10 nm41. However, in this study, the WC used was larger (10–20 nm) and therefore, we believe 
this might have been one factor that resulted in a lower antimicrobial impact.
In summary, metallic NPs were more effective when used in combination against S. aureus rather than alone 
and very potent antimicrobial effects were shown against P. aeruginosa when testing both SENP and NPC. This 
study shows the potential for a synergistic effect of NPs when placed in combination rather than using a single NP 
and for combinations to target a broad spectrum of both Gram-positive and Gram-negative bacteria. The data 
presented here give and overall assessment of the antimicrobial effect of NPs when in combination rather than on 
their own on two morphologically distinct pathogens. This work could be useful to healthcare practitioners and 
engineers in the development of medical devices that target a wide range of bacterial pathogens.
Materials and Methods
Nanoparticle preparation. Tungsten carbide (WC) and silver (Ag) NPs were engineered by Intrinsig 
Materials® (Farnborough, UK) using TesimaTM thermal plasma patented technology21. WC NPs were hexagonal 
in shape with an average diameter of 250 nm42. Dispersed WC NP aggregation suspenson at concentration 0.1 
wt/v% showed to have hydrodynamic sizes ranging from 180–220 nm with zeta surface charge of −21.7 kv at pH 
6.6. The Ag NPs were rod shaped and had particle sizes ranging from 80–90 nm in one dimension43. Dispersed 
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Ag NP aggregation suspension at concentration 0.1 wt/v% showed to have hydrodynamic sizes ranging from 
180–190 nm with zeta surface charge of −30.6 kv at pH 7.0. Copper (Cu) NPs were manufactured by Canfuo 
Nanotechnology® (Suzhou, China) and were 10–20 nm in diamter. The size information of the nanoparticles 
were provided by the manufacturing company. Dispersed Cu NP aggregation suspension at concentration 0.1 
wt/v% showed to have hydrodynamic sizes ranging from 180–190 nm with zeta surface charge of −8.82 kv at pH 
6.6. Saline solution (0.9 w/v% NaCl) was purchased from Fisher Scientific (Loughborough, England) and used 
as received.
For in vitro antimicrobial tests, antimicrobial nanoparticle formulations were prepared by suspending 1% 
wt/v of nano-powder composites (Table 1) into saline solution to collectively create the NPCs. In the case of Ag, 
1 ppm of ammonium solution (Fisher Schientific, UK) was added to aid forming uniform distribution of silver 
nanoparticles suspension. Each of these suspension were sonicated using a 750 W high-frequency ultrasonic 
probe (Sonics & Materials®, USA) with an applied ON/OFF pulse programme and 53% working power, mixtures 
were sonicated for 2–3 minutes until a well dispersed suspension was formed.
Growth of bacteria. Stock cultures of bacterial strains P. aeruginosa NCTC 12903 and S. aureus ATCC 
6538 P were stored in 30% glycerol. The strains were cultured on Tryptic Soya Agar (TSA, Sigma, England) and 
the plates were incubated at 37 °C for 24 hours. After incubation, a single colony of each bacterial strain was 
picked using a sterile loop and grown in 20 mL of Lennox I Broth (LB, Invitrogen, England) at 37 °C with constant 
agitation at 150 rpm for a further 24 hours. The bacterial cultures were then diluted 1:100 (equivalent to a cfu of 
108) and inoculated into the NP preparations (SENP and NPCs) at three different concentrations (0.05, 0.10 and 
0.25 w/v %) in LB, in triplicate and placed on a shaker for a further 24 hours. Controls included a negative control 
of LB only and NPs only, and a positive control of bacteria with no NP treatments.
Flow cytometry. To quantify the effects of the NPs on the bacterial populations, flow cytometry was used in 
conjuction with the LIVE/DEAD BacLight Bacterial Viability assay (ThermoFisher), to determine the proportion 
of live and dead cells after incubation with NPs. The fundamental principle of the assay relies on fluorescent dyes, 
Propidium Iodide (PI) and SYTO®9, to stain live and dead cell populations. PI is a red fluorescent interclating 
stain which penetrates cells with damaged membranes, whilst SYTO®9 is a green fluorescent nucleic stain which 
is able to penetrate both live and dead cells and bind to the nucleic acid. When both dyes are present, PI exhibits 
a stronger affinity for nucleic acids than SYTO®9, and hence, SYTO®9 is displaced by PI and a distinction can be 
made between live and dead cells44. A stock solution containing both dyes was prepared according to manufac-
turer’s recommendations. The staining solution was added to a 1:1000 dilution of the bacteria treated with SENPs 
and NPCs in microcentrifuge tubes, in triplicate with appropriate controls. After the stain was added, samples 
were incubated in the dark at room temperature for 15 minutes.
Post incubation, cells were acquired using a calibrated Guava easyCyte® flow cytometer (Merck, UK) using 
InCyte software (Merck, UK). Gates were set up accordingly using positive (bacteria only), negative (media only) 
and fluorescent minus one (FMO) controls (single stained positive controls). 50,000 events were collected overall 
and bacteria acquisition gates were determined using forward scatter and side scatter channels to eliminate back-
ground noise and debris from the sample. The gated population of bacteria was then analysed using fluorescent 
channels FL1 (live populations, SYTO®9) vs FL3 (dead populations, PI), as shown in Fig. 4.
FlowJo (V10, TreeStar, USA) was used to gate the live and dead bacterial cell counts where proportions of live 
and dead bacteria cells were calculated.
Statistical analysis. All analyses were performed using RStudio (v 1.0.136, USA), software with graphics 
coded via the ggplot2 package. The Shapiro-Wilk test was used to check the data for normality and subsequently a 
one-way ANOVA with post hoc TukeyHSD were performed. Significant difference was defined as P < 0.05.
Figure 4. Gating strategy example of S. aureus bacterial cells after exposure to Ag20Cu70WC10 as acquired by 
flow cytometry. Events are visualised as a density plot and gated using FlowJo V10 (Treestar, USA). (a) Live and 
dead proportion of cells after exposure to 0.05 w/v% nanoparticle combinations, (b) after exposure to 0.10 w/v 
% and (c) 0.25 w/v %. An increase in the number of dead cells and an increase in live is shown as concentration 
of Ag20Cu70WC10 increases. Events outside of gating (black lines) are excluded from the analysis as these are 
indeterminate events.
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